VEGFA and hypertensive disorder: As many of the potential target genes are uniformly expressed across tissue and cell types, strategies to mitigate unwanted silencing in clearance and other organ systems may be necessary to reduce potential systemic side effects like VEGF-mediated hypertension or systemic immune repression.